Cencora (COR) Stock: Buy, Sell, or Hold?
COR - Cencora, Inc.
$337.87
-2.56 (-0.75%)
▼
5d:
-1.04%
30d:
+8.19%
90d:
+9.03%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 04, 2026
12d
Get Alerted When COR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: COR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: COR shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$461.97
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$286.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: COR is currently trading at $337.87, which is considered extended relative to its 30-day fair value range of $307.74 to $332.82. The stock's valuation (Forward PE: 17.2) is in line with its historical norms (16.5). At these levels, the market is pricing in 1.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, COR is in a strong uptrend. The price is approaching resistance at $345.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: COR scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, COR is in a strong uptrend. The price is approaching resistance at $345.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: COR scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$307.74 -
$332.82
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
24.8%
Protect Your Profits
Holding COR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($367.67)
- NEUTRAL: Market pricing in 1.5% annual earnings growth - fairly valued
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$307.74 -
$332.82
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$318.79
Resistance Level
$345.46
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.23
Wall Street Target
$367.67
(+8.0%)
Revenue Growth (YoY)
5.1%
Earnings Growth (YoY)
11.9%
Profit Margin
0.8%
Valuation Premium vs History
+1.5% premium
PE vs Historical
17.2 vs 16.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.5%
(market-implied from PE analysis)
1-Year Target
$345.54
(+2%)
2-Year Target
$350.72
(+3%)
3-Year Target
$355.98
(+5%)
3-Yr Target (if PE normalizes)
(PE: 17→17)
PE COMPRESSION
$340.82
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 10.5%)
$529.12
(+55%)
Base:
(SPY PE: 17.2, Growth: 10.5%)
$459.17
(+35%)
Bear:
(PE: 14.6, Growth: 10.5%)
$390.29
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 25.24 | Current EPS (TTM): $13.60
Bull Case
$548.44
(+61%)
Analyst growth 45.2%, PE expands to 27.8
Base Case
$498.58
(+47%)
Market implied 45.2%, PE stable at 25.2
Bear Case
$233.42
(-31%)
Severe decline -20.0%, PE contracts to 21.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 3:28 PM ET
Data refreshes hourly during market hours. Next update: 4:28 PM
Data refreshes hourly during market hours. Next update: 4:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CAH
Cardinal Health Inc |
STRONG BUY
17 analysts |
$271 | 31 SELL |
|
MCK
McKesson Corporation |
STRONG BUY
16 analysts |
$1001 | 36 SELL |
|
HSIC
Henry Schein Inc |
BUY
16 analysts |
$97 | 59 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 46 HOLD |
Advanced COR Option Strategies
Professional options setups generated by AI based on today's COR price and gamma walls.
